Literature DB >> 15100930

Multimodality stereotactic approach to the treatment of cystic craniopharyngiomas.

A Nicolato1, R Foroni, L Rosta, M Gerosa, A Bricolo.   

Abstract

OBJECTIVES: To present the therapeutic reliability of a multimodality stereotactic approach (MSA) to cystic craniopharyngiomas (CPs), combining neuroendoscopy, intracavitary bleomycin and gamma knife (GK) radiosurgery.
METHODS: 8 patients with mono- or multicystic CP (7/8 regrowths/recurrence) underwent stereotactic neuroendoscopy and subsequently treatment with intracavitary bleomycin and GK. They were clinically characterized by hypopituitarism (7 cases), visual impairment (7), endocranial hypertension (7), cognitive and behavioral disturbances (3), and cranial nerve deficits or focal signs (3). Concomitant hydrocephalus was observed in 3/8 patients. According to Backlund's classification, the treated CPs were classified as type A (3 cases), type Cc (4 cases) and type Dc (1 case). In all 8 patients, neuroendoscopy allowed evacuation of the cyst and, in multi-cystic CPs, fenestration of the interposed septa so as to create a single communicating cavity. Thus, a single catheter and Ommaya reservoir system was sufficient both for subsequent aspirations and for bleomycin injection (doses of 1.5-3 mg, usually repeated every 7-8 days, with total doses ranging from 3-35 mg). GK radiosurgery was carried out at a later stage on the collapsed cyst in type A forms, while in types Cc and Dc, it was used on the solid nodule on the same day as the neuroendoscopy.
RESULTS: The median follow-up period was 42.5 months. Neurological improvement was observed in 8/8 patients. A complete response (reduction of the entire tumor volume > 90 %) was observed in 3/8 cases (type A), a subtotal response (reduction > 50 %) in 4/8 cases (types Cc and Dc), and a partial response (reduction < 50 %) in 1/8 cases (type Cc). Treatment of CP alone led to normalization of the ventricular morphology in the 3 patients with associated hydrocephalus. Transient GK-related visual worsening was recorded in one case only. One patient died because of ventriculitis after repeated shunt replacements.
CONCLUSIONS: This MSA seems to be an effective and safe treatment alternative to microsurgery, above all in patients with regrowing/recurrent cystic CPs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15100930     DOI: 10.1055/s-2003-812467

Source DB:  PubMed          Journal:  Minim Invasive Neurosurg        ISSN: 0946-7211


  5 in total

1.  Unusual association of a pituitary adenoma and a neurological emergency: case report and diagnostic steps.

Authors:  Marina Baldini; Lorena Airaghi; Alessandra Orsatti; Alberto Tedeschi; Tiziana Ceraldi; Clara Sina; Maria Domenica Cappellini
Journal:  Intern Emerg Med       Date:  2008-02-22       Impact factor: 3.397

2.  Upfront adjuvant irradiation versus postoperative surveillance following incomplete surgical resection of craniopharyngiomas in children and young adults.

Authors:  Sauradeep Sarkar; Sophy Korula; Sarah Mathai; Anna Simon; Rajesh Balakrishnan; Selvamani Backianathan; Ari G Chacko
Journal:  Childs Nerv Syst       Date:  2022-08-09       Impact factor: 1.532

3.  Endoscopic Transcortical Transventricular Management of Cystic Craniopharyngioma: Outcome Analysis of 32 Cases at a Tertiary Care Center.

Authors:  Somil Jaiswal; Manish Jaiswal; Pooja Jaiswal; Ankur Bajaj; Chhitij Srivastava; Anil Chandra; Bal Krishna Ojha; Janu Vikas; Awadhesh Yadav
Journal:  Asian J Neurosurg       Date:  2020-12-21

Review 4.  The Role of Surgical Approaches in the Multi-Modal Management of Adult Craniopharyngiomas.

Authors:  Christopher S Hong; Sacit Bulent Omay
Journal:  Curr Oncol       Date:  2022-02-24       Impact factor: 3.677

5.  Stereotactic cysto-ventricular catheters in craniopharyngiomas: an effective minimally invasive method to improve visual impairment and achieve long-term cyst volume reduction.

Authors:  Christine Steiert; Juergen Grauvogel; Roland Roelz; Theo Demerath; Daniel Schnell; Juergen Beck; Volker Arnd Coenen; Peter Christoph Reinacher
Journal:  Neurosurg Rev       Date:  2021-03-05       Impact factor: 3.042

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.